Antimicrobial catheters in the ICU: is the juice worth the squeeze?
Open Access
- 1 January 2009
- journal article
- editorial
- Published by Springer Nature in Critical Care
- Vol. 13 (3) , 148
- https://doi.org/10.1186/cc7793
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decisionCritical Care, 2009
- Intravascular catheter-related infections: advances in diagnosis, prevention, and managementThe Lancet Infectious Diseases, 2007
- Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital*Critical Care Medicine, 2006
- Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream InfectionsClinical Infectious Diseases, 2005
- The Promise of Novel Technology for the Prevention of Intravascular Device–Related Bloodstream Infection. II. Long‐Term DevicesClinical Infectious Diseases, 2002
- The role of intravascular devices in sepsisCurrent Infectious Disease Reports, 2001
- Outcomes of Primary and Catheter-related BacteremiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Increased Resource Use Associated With Catheter-Related Bloodstream Infection in the Surgical Intensive Care UnitArchives of Surgery, 2001
- CATHETER-RELATED COMPLICATIONS OF CANCER THERAPYInfectious Disease Clinics of North America, 1996
- Intravascular device-related infections in cancer patientsPublished by Springer Nature ,1995